Status Asthmaticus on the Intensive Care Prospective - STATIC PRO
Risk Factors for Intensive Care Admission of Children With Severe Acute Wheeze or Asthma (SAA)
1 other identifier
observational
221
1 country
1
Brief Summary
This study will prospectively assess the impact and relevance of several risk factors for children with severe acute asthma (SAA) or acute wheeze that have been identified in retrospective studies. Secondary we will assess short-term medical and psychosocial functioning in patient (and parents) admitted to a PICU for SAA/acute wheeze versus a control group admitted to a MC for SAA/acute wheeze.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Aug 2016
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2016
CompletedFirst Submitted
Initial submission to the registry
October 12, 2016
CompletedFirst Posted
Study publicly available on registry
October 18, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2019
CompletedMay 23, 2019
May 1, 2019
2.7 years
October 12, 2016
May 21, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Undertreatment in children admitted to a PICU with a diagnosis of SAA/acute wheeze
Undertreatment is defined as: Patient is not using inhaled corticosteroids (ICS), or Patient is using ICS \< 7 days (counting from moment of admission to emergency department) according to treatment plan, or Patient is not using ICS according tot treatment plan.
Within the time of admission on the PICU/MC, preferably within 48 hours and during follow up after 3-6 months
Secondary Outcomes (5)
Exposure to triggers (single or combined)
Within the time of admission on the PICU/MC, preferably within 24 hours
Socio-economic status
Within the time of admission on the PICU/MC
Frequency of previous asthma-related hospital admissions and/or PICU admissions.
Within the time of admission on the PICU/MC and during follow up after 3-6 months
Severity of disease, defined using the GINA criteria for stepwise management of asthma.
Within the time of admission on the PICU/MC, preferably within 48 hours and during follow up after 3-6 months
Distribution of ADRB2-receptor polymorphisms compared to non-SAA population.
Through study completion, preferably within the time of admission on the PICU/MC
Study Arms (2)
PICU (= case group)
Children aged 2-18 years admitted to a Paediatric Intensive Care Unit in the Netherlands, with a diagnosis of acute wheeze or SAA.
MC (= control group)
Children aged 2-18 years admitted to a Medium Care in the Netherlands, with a diagnosis of acute wheeze or SAA.
Eligibility Criteria
Children aged 2-18 years admitted to a Medium Care or Paediatric Intensive Care Unit in the Netherlands, with a diagnosis of acute wheeze or SAA.
You may qualify if:
- Between 2 and 18 years of age
- Admission to a PICU for SAA or acute wheeze or admission to a MC for SAA or acute wheeze
You may not qualify if:
- Patient is outside of specified age range
- Down's Syndrome
- Congenital/acquired heart defect that interferes with normal SAA treatment
- Congenital/acquired airway defect (tracheomalacia/bronchomalacia)
- Primary/secondary immunodeficiency
- Pre-existing chronic pulmonary condition, known to mimic asthma: Cystic Fibrosis, Bronchopulmonary dysplasia, Bronchiolitis obliterans
- If both parents are not able to speak the Dutch language
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Erasmus Medical Centerlead
- Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)collaborator
- Radboud University Medical Centercollaborator
- Maasstad Hospitalcollaborator
- Amsterdam UMC, location VUmccollaborator
- UMC Utrechtcollaborator
- University Medical Center Groningencollaborator
- Amphia Hospitalcollaborator
- Rijnstate Hospitalcollaborator
- Tergooi Hospitalcollaborator
- Maastricht University Medical Centercollaborator
- Leiden University Medical Centercollaborator
Study Sites (1)
Erasmus MC
Rotterdam, South Holland, 3000WB, Netherlands
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Prof. Dr.
Study Record Dates
First Submitted
October 12, 2016
First Posted
October 18, 2016
Study Start
August 1, 2016
Primary Completion
April 1, 2019
Study Completion
April 1, 2019
Last Updated
May 23, 2019
Record last verified: 2019-05